About Glimepiride And Metformin Hydrochloride Extended Release Tablets IP
Glimepiride and Metformin Hydrochloride Extended Release Tablets IP are formulated to help adults manage their blood sugar levels effectively. With a dosage of 2 mg of Glimepiride and 500 mg of Metformin Hydrochloride, these tablets offer a reliable solution for maintaining glycemic control in individuals with Type 2 diabetes. Designed as extended-release tablets, they ensure sustained action throughout the day. Their physical form, convenient tablet size, makes them easy to consume. The product is packaged in a quantity of 10*10 pieces and must be stored at room temperature to maintain its efficacy. As a general therapeutic medicine, it is recommended to use these tablets under the guidance of a healthcare professional.
FAQs of Glimepiride And Metformin Hydrochloride Extended Release Tablets IP:
Q: What is the primary purpose of these tablets?
A: These tablets are intended for managing blood sugar levels in adults suffering from Type 2 diabetes.
Q: How should the tablets be stored?
A: They should be stored at room temperature to ensure their effectiveness is maintained.
Q: What is the dosage of these tablets?
A: Each tablet contains 2 mg of Glimepiride and 500 mg of Metformin Hydrochloride.
Q: How are these tablets packaged?
A: The tablets are supplied in a quantity of 10*10 pieces per package.
Q: Who can use these tablets?
A: These tablets are suitable for adults and should be consumed under medical supervision.